This World Immunisation Week and beyond, MSF teams share access and innovation advancements that, if achieved in the years to ...

Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based ...

For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...

Kathleen Elison is the co-founder and principal scientist at Terray Therapeutics, where she leads the research and ...

Conclusion: ATG-125 demonstrated synergistic IO+ADC antitumor activity through a differentiated mechanism combining enhanced internalization for payload delivery with the potential to restore ...

Abstract: Recent studies have demonstrated microarray expression data can be used to identify gene regulatory pathways. However, one of the major challenges is to utilize the large microarray data ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Pimple patches seem to be soaring in popularity—and a newly invented ...

BRISBANE, Australia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering ...

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...

According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...